Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.49 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.49 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.49 |
| ▸ | TYR | P14679 | 4/20 | 0.48 |
| ▸ | IGF2R | P11717 | 2/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | GJA1 | P17302 | 1/20 | 0.45 |
| ▸ | GJB2 | P29033 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12563491 | 0.92 | TYR (0.56) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL12902015 | 0.92 | TYR (0.56) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL12604931 | 0.92 | TYR (0.56) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL12563490 | 0.92 | TYR (0.56) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL12901988 | 0.92 | TYR (0.56) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL16207269 | 0.91 | CD209 (0.43) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL25142277 | 0.89 | CD209 (0.55) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL22224176 | 0.87 | ALDH1A1 (0.43) | TYRALDH1A1L3MBTL1 | |
| SCHEMBL20713712 | 0.87 | L3MBTL1 (0.51) | TYRPTPN1ALDH1A1L3MBTL1 | |
| SCHEMBL20713676 | 0.87 | L3MBTL1 (0.51) | TYRPTPN1ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10443026-B2 | Polygonal scaffold and manufacturing method thereof, and protein modulator and manufacturing method thereof | NATIONAL TSING HUA UNIVERSITY (TW) | 2019-10-15 | — | — | US | disclosed |
| US-20190194590-A1 | POLYGONAL SCAFFOLD AND MANUFACTURING METHOD THEREOF, AND PROTEIN MODULATOR AND MANUFACTURING METHOD THEREOF | NATIONAL TSING HUA UNIVERSITY (TW) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194590-A1 | POLYGONAL SCAFFOLD AND MANUFACTURING METHOD THEREOF, AND PROTEIN MODULATOR AND MANUFACTURING METHOD THEREOF | PPIA, PPIH, FKBP1A | MEN1 2696/4885KMT2A 3944/4885LGALS8 3873/4885 |
| US-10443026-B2 | Polygonal scaffold and manufacturing method thereof, and protein modulator and manufacturing method thereof | PPIA, PPIH, FKBP1A | MEN1 2677/4885KMT2A 3765/4885LGALS8 4198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.